Market Overview

5 Stocks To Watch For November 27, 2020

5 Stocks To Watch For November 27, 2020

Some of the stocks that may grab investor focus today are:

  • Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) reported that the FDA has approved its DANYELZA for the treatment of neuroblastoma. Y-mAbs Therapeutics shares jumped 10.3% to $48.25 in the after-hours trading session.
  • Walt Disney Co (NYSE: DIS) announced plans to lay off 32,000 workers, a rise from the 28,000 it reported in September. Disney shares gained 0.3% to $149.48 in the after-hours trading session.
  • AstraZeneca plc’s (NYSE: AZN) CEO said the company is likely to run new global trial on its COVID-19 vaccine after interim results from its trial showed 62% efficacy for a full dosage regimen. AstraZeneca shares fell 0.1% to $52.55 in the after-hours trading session.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Choosing the best broker is an important part of being a successful trader or investor

  •, Inc. (NASDAQ: AMZN) announced plans to give more than $500 million in holiday bonuses to its front-line employees in the US. The holiday season in the country is also expected to drive the company’s online retail traffic. Amazon shares rose 0.1% to $3,187.18 in after-hours trading.
  • Inpixon (NASDAQ: INPX) reported the pricing of $10 million registered offering priced at-the-market at $1.25. Inpixon shares rose 0.9% to $1.19 in after-hours trading.

Related Articles (AMZN + AZN)

View Comments and Join the Discussion!

Posted-In: Stocks To WatchNews Penny Stocks Small Cap Pre-Market Outlook Markets Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at